Home » Topics » BioWorld Science

BioWorld Science
RSS

Nippon Shoji's newest ACAT inhibitors

Sep. 27, 1996

Kyowa Hakko describes protein inducing osteoblast proliferation

Sep. 27, 1996

Takeda's anticancer drug pipeline reviewed

Sep. 27, 1996

Anticataract and NGF production-enhancing compounds

Sep. 27, 1996

Promising preclinical and clinical results for Genta's lead antisense compound

Sep. 27, 1996

Clinical benefits of p53 gene therapy

Sep. 27, 1996

Antisense compound displays activity in animal models of human cancer

Sep. 27, 1996

Clinical trial of gene therapy for malignant brain tumors

Sep. 27, 1996

ET-743 product overview and development update

Sep. 27, 1996

Japanese researchers report new antiangiogenic compound

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026